Showing posts with label Compounding Oversight May Hinge On How FDA Treats Office Stock. Show all posts
Showing posts with label Compounding Oversight May Hinge On How FDA Treats Office Stock. Show all posts

Monday, February 10, 2014

Compounding Oversight May Hinge On How FDA Treats Office Stock

 


Executive Summary

Pew asks FDA to look at large-scale compounders of office stocks and help encourage them to register, but IACP argues regulation of the office stock should remain with the states.